DUBLIN--(BUSINESS WIRE)--Research and Markets (http://www.researchandmarkets.com/research/sl6r47/biomarkers_in) has announced the addition of the "Biomarkers in Alzheimer's Disease - Overview " report to their offering.
Biomarkers have been a heavily studied topic of interest, and recently on the rise is the interest in neurodegenerative disorders, particularly Alzheimer's Disease. Although there are many techniques used to track neurodegenerative disease progression, this report will primarily focus on blood-based and cerebrospinal fluid-based biomarkers for this disease. In addition to covering extensive background information, this report will also highlight market growth and outlook, and feature clinical trial and pipeline information.
Biomarkers in Alzheimer's Disease is focused on biomarker identification and development in patients with Alzheimer's Disease. This report focuses on the Alzheimer's Disease space featured in the parent report, highlighting several biomarker targets under investigation and the progress that has been made in the industry. With regards to employing the use of biomarkers for Alzheimer's Disease, Biomarkers in Alzheimer's Disease captures market growth of biomarkers, advantages, disadvantages, and validation techniques.
Also available in this report is extensive survey data exclusively conducted for this report. Illustrated by 30 figures captured in an in-depth analysis, this section features insight into targets under investigation, challenges, advantages, and desired features of future diagnostic applications.
Finally, this report comes with clinical trial and pipeline data featuring targets and products from over 200 companies working in Alzheimer's Disease.
Key Topics Covered:
Chapter 1: The Focus of this Report
Chapter 2: Biomarkers and Their Clinical Utility
Chapter 3: Biomarkers in Neurodegenerative Disorders
Chapter 4: Mild Cognitive Impairment and Alzheimer's Disease
Chapter 5: Biomarkers for Diagnostics
Chapter 6: Survey Results
Chapter 7: Clinical Trials and Pipeline Information
For more information visit http://www.researchandmarkets.com/research/sl6r47/biomarkers_in